Welcome
Support Centre
25 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Community-effectiveness of the distribution of insecticide-treated bed nets through social marketing antenatal care services in malaria control in rural Burkina Faso
ISRCTN ISRCTN07985309
DOI 10.1186/ISRCTN07985309
ClinicalTrials.gov identifier
EudraCT number
Public title Community-effectiveness of the distribution of insecticide-treated bed nets through social marketing antenatal care services in malaria control in rural Burkina Faso
Scientific title
Acronym N/A
Serial number at source D4
Study hypothesis There is the highly controversial question how African programmes can best reach a sustainable high coverage with Insecticide-Treated bed Nets (ITNs) in young children and pregnant women. Against this background a cluster randomised controlled trial is implemented in Nouna Health District in Burkina Faso to compare two different forms of distribution of ITNs.
Lay summary
Ethics approval The protocol has been reviewed and approved by the Ethics Committee of the University of Heidelberg (date: 12 th November 2004, ref: L-357/2004) and the local Ethics Committee in Nouna, Burkina Faso.
Study design Cluster-randomised controlled trial. Evaluation takes place through annual representative household surveys.
Countries of recruitment Burkina Faso
Disease/condition/study domain Malaria
Participants - inclusion criteria Households with children under five years of age.
Participants - exclusion criteria No exclusion criteria.
Anticipated start date 01/08/2006
Anticipated end date 30/12/2008
Status of trial Completed
Patient information material
Target number of participants sample size: 500 per study arm
Interventions Twenty-four peripheral health centres and their catchment areas were randomised to:
1. ITN provision to the general population through social marketing, and
2. ITN provision to the general population through social marketing plus free provision to all pregnant women through antenatal services

The total duration of the intervention will be three years, and participants will be followed up for a further two years.
Primary outcome measure(s) 1. ITN coverage in households 12 and 24 months after the start of the interventions
2. ITN use during pregnancy and infancy
Secondary outcome measure(s) 1. Costs per malaria case and per Disability Adjusted Life Years (DALY) prevented
2. Self-reported information on Antenatal Clinic (ANC) visits
3. Insecticide content on ITN and mortality of vector mosquitoes over time
4. Acceptance of health staff and population

Outcomes will be measured at 12 and 24 months after the start of the interventions
Sources of funding German Research Foundation (Deutsche Forschungsgemeinschaft [DFG]) (Germany) - Special Research Area of Control of Tropical Infectious Diseases (Sonderforschungsbereich [SFB] 544)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/pubmed/18784840
Contact name Prof  Olaf  Mueller
  Address Im Neuenheimer Feld 324
  City/town Heidelberg
  Zip/Postcode 69120
  Country Germany
Sponsor University Hospital Heidelberg (Universitätsklinikum Heidelberg) (Germany)
  Address Im Neuenheimer Feld 672
  City/town Heidelberg
  Zip/Postcode 69120
  Country Germany
  Sponsor website: http://www.klinikum.uni-heidelberg.de/
Date applied 16/07/2007
Last edited 19/09/2008
Date ISRCTN assigned 19/07/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.